Abstract:ABSTRACT Accurate and timely diagnosis of severe acute respiratory syndrome coronavirus (SARS-CoV) infection is a critical step in preventing another global outbreak. In this study, 829 serum specimens were collected from 643 patients initially reported to be infected with SARS-CoV. The sera were tested for the N protein of SARS-CoV by using an antigen capture enzyme-linked immunosorbent assay (ELISA) based on monoclonal antibodies against the N protein of SARS-CoV and compared to 197 control serum samples from healthy donors and non-SARS febrile patients. The results of the N protein detection analysis were directly related to the serological analysis data. From 27 SARS patients who tested positive with the neutralization test, 100% of the 24 sera collected from 1 to 10 days after the onset of symptoms were positive for the N protein. N protein was not detected beyond day 11 in this group. The positive rates of N protein for sera collected at 1 to 5, 6 to 10, 11 to 15, and 16 to 20 days after the onset of symptoms for 414 samples from 298 serologically confirmed patients were 92.9, 69.8, 36.4, and 21.1%, respectively. For 294 sera from 248 serological test-negative patients, the rates were 25.6, 16.7, 9.3, and 0%, respectively. The N protein was not detected in 66 patients with cases of what was initially suspected to be SARS but serologically proven to be negative for SARS and in 197 serum samples from healthy donors and non-SARS febrile patients. The specificity of the assay was 100%. Furthermore, of 16 sera collected from four patients during the SARS recurrence in Guangzhou, 5 sera collected from 7 to 9 days after the onset of symptoms were positive for the N protein. N protein detection exhibited a high positive rate, 96 to 100%, between day 3 and day 5 after the onset of symptoms for 27 neutralization test-positive SARS patients and 298 serologically confirmed patients. The N protein detection rate continually decreased beginning with day 10, and N protein was not detected beyond day 19 after the onset of symptoms. In conclusion, an antigen capture ELISA reveals a high N protein detection rate in acute-phase sera of patients with SARS, which makes it useful for early diagnosis of SARS.

Dynamic Observation to SARS-CoV Antibody and Antigen in Late 2003 in Guangdong

Dynamic Changes in IgG and IgM Antibodies As Clinical Indicators During Recovery Stage in Patients with Severe Acute Respiratory Syndrome

Dynamic Changes of Viral Load and Antibodies Level in the Patients of Severe Acute Respiratory Syndrome

Dynamic Characteristic Analysis of Antibodies in Patients with COVID-19: A 13-Month Study

Antibody Detection and Dynamic Characteristics in Patients With Coronavirus Disease 2019

[A Follow Up Study of Total IgM, IgG, Nucleoprotein and Spike Protein Antibodies Against Severe Acute Respiratory Syndrome (SARS) Coronavirus in Patients with SARS].

Study on the Response of Specific Antibodies Against SARS-CoV in Patients Infected with SARS

Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients

Antibody Test of Different SARS Pathogens in the Serum Samples of the Clinically Diagnosed Cases of Infectious Severe Acute Respiratory Syndrome

Monoclonal Antibody-Based Antigen Capture Enzyme-Linked Immunosorbent Assay Reveals High Sensitivity of the Nucleocapsid Protein in Acute-Phase Sera of Severe Acute Respiratory Syndrome Patients.

Dynamic Changes of IgM and IgG Antibodies in Asymptomatic Patients As an Effective Way to Detect SARS‐CoV‐2 Infection

The detection of IgG antibody to SARS-associated coronavirus in SARS cases in Guangdong province

The Follow-up Study on the Health Status of Convalescent Patients Recovered from SARS in Tianjin

Longitudinal Profile of Antibodies Against Sars-Coronavirus in Sars Patients and Their Clinical Significance

Longitudinal Change of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies in Patients with Coronavirus Disease 2019.

Kinetics Of Severe Acute Respiratory Syndrome (Sars) Coronavirus-Specific Antibodies In 271 Laboratory-Confirmed Cases Of Sars

[Primary Investigation on the Changing Mode of Plasma Specific IgG Antibody in SARS Patients and Their Physicians and Nurses].

Longitudinal profiles of immunoglobulin G antibodies against severe acute respiratory syndrome coronavirus components and neutralizing activities in recovered patients.

Laboratory Detection on Severe Acute Respiratory Syndrome

Profiles Of Igg Antibodies To Nucleocapsid And Spike Proteins Of The Sars-Associated Coronavirus In Sars Patients

Detection of the Nucleocapsid Protein of Severe Acute Respiratory Syndrome Coronavirus in Serum: Comparison with Results of Other Viral Markers